Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company ...

As you begin your hybrid quantum approach, here are the advantages, use cases and limitations to keep in mind.

Soon, researchers may be able to create movies of their favorite protein or virus better and faster than ever before. Researchers at the Department of Energy's SLAC National Accelerator Laboratory ...

The market is rapidly shifting toward proactive, data-driven strategies. A focus on integrating artificial intelligence and ...